ADCT
ADCT
Positions held
Your positionsADCT isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Sector Update: Healthcare Stocks Softer Late Afternoon
2026-10-08 · Sector Update: Healthcare Stocks Decline in Afternoon Trading
2026-10-08 · ADC Therapeutics Shares Rise After Financial Restructuring Extends Cash Runway
2026-10-08 · ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
2026-09-03 · ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
2026-08-27 · ADC Therapeutics (ADCT) Navigates FDA Setback While Cutting Its Losses
2026-08-20 · ADC Therapeutics (ADCT) Q2 2026 Earnings Call Transcript
2026-08-16 · ADC Therapeutics (ADCT) Stock Fair Value Falls After LOTIS 5 Reshapes Zynlonta Outlook
2026-08-14 · ADC Therapeutics Balances LOTIS-5 Regulatory Risk With LOTIS-7 Opportunity, RBC Says
2026-08-14 · ADC Therapeutics S.A. Q2 2026 Earnings Call Summary
2026-08-13 · ADC Therapeutics SA (ADCT) (Q2 2026) Earnings Call Highlights: Navigating Regulatory Hurdles ...
2026-08-13 · ADC Therapeutics Q2 Earnings Call Highlights
Price (daily)
Full chart · RSI · MACD · patterns